Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.0112
-0.0019 (-14.50%)
Jan 5, 2026, 4:00 PM EST
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $54.37 thousand as of January 6, 2026. Its market cap has decreased by -96.80% in one year.
Market Cap
54.37K
Enterprise Value
1.72M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 19, 2015, Panbela Therapeutics's market cap has decreased from 89.28M to 54.37K, a decrease of -99.94%. That is a compound annual growth rate of -51.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 54.37K | 5,499.79% |
| Dec 31, 2025 | 971.00 | -99.95% |
| Dec 31, 2024 | 1.84M | -70.55% |
| Dec 29, 2023 | 6.27M | 109.12% |
| Dec 30, 2022 | 3.00M | -87.09% |
| Dec 31, 2021 | 23.21M | -32.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |